Cartesian Therapeutics
RNAC
#6926
Rank
HK$3.56 B
Marketcap
HK$140.18
Share price
-1.47%
Change (1 day)
-17.85%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -HK$2.07 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are HK$47.93 Million. In 2023 the company made an earning of -HK$1.84 Billion a decrease over its 2022 earnings that were of HK$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$2.07 Billion12.42%
2023 -HK$1.84 Billion-724%
2022 HK$0.29 B-649.67%
2021 -HK$53.44 Million-89.78%
2020 -HK$0.53 Billion25.06%
2019 -HK$0.42 Billion-15.68%
2018 -HK$0.5 Billion-0.43%
2017 -HK$0.5 Billion83.41%
2016 -HK$0.28 Billion44.3%
2015 -HK$0.19 Billion